Bide Pharmatech Co., Ltd. (SHA:688073)

China · Delayed Price · Currency is CNY

63.71

-0.49 (-0.76%)

Sep 9, 2026, 4:00 PM EDT

Bide Pharmatech Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,379	1,324	1,102	1,092	833.83	606.22
Revenue Growth	15.18%	20.13%	0.93%	30.95%	37.55%	54.86%
Gross Profit	617.11	550.48	421.66	418.48	362.54	290.33
Operating Income	243.42	187.67	112.99	99.3	144.34	107.58
Net Income	181.64	151.74	117.43	109.57	145.97	97.57
Earnings Per Share	2.08	1.73	1.32	1.21	1.98	1.46
EPS Growth	31.49%	31.06%	9.09%	-38.89%	35.89%	53.38%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	564.53
Overseas	759.27
Total	1,324

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,023	1,041	1,181	1,274	1,510	193.46
Total Debt	136.91	141.07	82.2	57.3	40.82	27.78
Net Cash (Debt)	885.69	900.41	1,099	1,217	1,469	165.68
Net Cash Growth	-5.75%	-18.04%	-9.72%	-17.17%	786.71%	40.92%
Net Cash Per Share	10.13	10.27	12.35	13.44	19.93	2.47

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	103.84	28.32	158.31	-57.39	29.87	-64.88
Capital Expenditures	-22.31	-24.28	-88.35	-61.08	-38.41	-29.2
Free Cash Flow	81.53	4.04	69.97	-118.47	-8.54	-94.09
Free Cash Flow Growth	-	-94.23%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	44.75%	41.58%	38.26%	38.33%	43.48%	47.89%
Operating Margin	17.65%	14.18%	10.25%	9.09%	17.31%	17.75%
Pretax Margin	16.79%	14.76%	13.43%	11.54%	20.60%	18.90%
Profit Margin	13.17%	11.46%	10.66%	10.04%	17.51%	16.10%
FCF Margin	5.91%	0.30%	6.35%	-10.85%	-1.02%	-15.52%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	1.160	1.160	0.900	0.900	1.100
Dividend Per Share Growth	28.89%	28.89%	0%	-18.18%	-
Dividend Yield	1.92%	1.95%	1.92%	1.75%	2.04%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	30.66	34.66	36.98	46.03	36.53	-
Forward PE	-	27.56	31.74	22.50	30.12	-
P/FCF Ratio	67.32	1301.79	62.06	-	-	-
PS Ratio	3.98	3.97	3.94	4.62	6.40	-